GRb1, one of the ginsenosides, has multiple pharmacological activities such as anti-fatigue, anti-oxidation, neuroprotection, anti-inflammation, and anti-diabetes (Du et al., 2011; Shergis et al., 2013). This evidence concerns the gene PIK3R1 and diabetes mellitus.